Independent epidemics of heterosexual and homosexual HIV infection in South Africa - Survival differences

QJM: An International Journal of Medicine

Volumn 90, Issue 7, 1997, Pages 449-454

  Maartens, G ^a,c   Wood, R ^b   O'Keefe, E ^b   Byrne, C ^a  

^a Departments of Medicine   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Medical School   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CENTRAL AFRICA; DEVELOPED COUNTRY; DISEASE COURSE; DISEASE SEVERITY; EPIDEMIC; EUROPE; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MORBIDITY; NORTH AMERICA; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; SOCIAL CLASS; SOUTH AFRICA; SURVIVAL; TUBERCULOSIS; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 0030844958     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.7.449     Document Type: Article

References (22)

1. Gilks CF. The clinical challenge of the HIV epidemic in the developing world. Lancet 1993; 342:1037-9.
2. Mulder DW, Nunn AJ, Kamali A, Nakiyingi J, Wagner H-U, Kengeya-Kayondo JF. Two-year HIV-1-associated mortality in a Ugandan rural population. Lancet 1994; 343:1021-3.
3. Lucas SB. Missing infections in AIDS. Trans Roy Soc Trop Med Hyg 1990; 84 (Suppl 1):34-8.
4. Anzala OA, Nagelkere NJ, Bwayo JJ, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995; 171:686-9.
5. van Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson A-L, Williamson C. HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS 1997; 11:81-7.
6. Benatar SR. Medicine and health care in South Africa - five years later. N Engl J Med 1991; 325:30-6.
7. Centers for Disease Control. Revision of the CDC surveillance case definition for Acquired Immunodeficiency Syndrome. MMWR 1987; 36 (Suppl 1S):3S-14S.
8. Darby SC, Ewart DW, Giangrande PL, Spooner RJ, Pizza CR. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet 1996; 347:1573-9.
9. Lundgren JD, Pedersen C, Clumeck N, et al. Survival differences in European patients with AIDS, 1979-89. Br Med J 1994; 308:1068-73.
10. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41(RR-17):1-19.
11. Brettle RP, Gore SM, Bird AG, McNeil AJ. Clinical and epidemiolological implications of the Centers for Disease Control/World Health Organization reclassification of AIDS cases. AIDS 1993; 7:531-9.
12. Veugelers PJ, Schlechter MT, Tindall B, et al. Differences in time from HIV seroconversion to CD4+ lymphocyte endpoints and AIDS in cohorts of homosexual men. AIDS 1993; 7:1325-9.
13. Mukadi Y, Perriens JH, StLouis ME, et al. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet 1993; 342:143-6
14. Yach D. Tuberculosis in the Western Cape health region of South Africa. Soc Sci Med 1988; 27:683-9.
15. Nee EE. Mycobacterium avium complex serovars isolated in South Africa from humans, swine and the environment. Rev Infect Dis 1981; 3:1013-17.
16. Bermudez LE, Inderlied CB, Young LS. Mycobacterium avium complex in AIDS. In: Current Clinical Topics in Infectious Diseases, Vol 12. Boston, Blackwell, 1992:257-81.
17. Trnka L, Dankova D, Svandova E. Six years experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. Tubercle Lung Dis 1994; 75:348-52.
18. Hogg RS, Strathdee SA, Craib KJ, O'Shaughnessy, Montaner JS, Schechter MT. Lower socioeconomic status and shorter survival following HIV infection. Lancet 1994; 344:1120-4
19. Chaisson R, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med 1995; 333:751-6.
20. Kaerstaedt AS. AIDS - the Baragwanath experience. Part III. HIV infection in adults. S Afr Med J 1992; 82:95-7.
21. Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med 1987; 317:1297-302.
22. Apolonio EG, Hoover DR, He Y, et al. Prognostic factors in human immunodeficiency virus-positive patients with a CD4+ lymphocyte count < 50/μl. J Infect Dis 1995; 171:829-36.